Published: 28 August 2026
Consultations
Outcome of the consultation on proposed changes to the classification of vitamin D pursuant to the Medicines Regulations 1984
Summary
- Medsafe sought feedback on a proposal to increase the amount of vitamin D that is permitted in a general sale medicine from 25 micrograms (1,000 IU) to 50 micrograms (2,000 IU). This proposal was informed by an independent expert opinion, based on a comprehensive review of current literature.
- We received 25 responses to this consultation.
- Download the consultation outcome document (PDF document, 606 KB, 25 pages) to view the consultation feedback, Medsafe’s response, and the final outcome.
About the Consultation
From 5 March to 2 April 2026, Medsafe sought feedback on the proposal to increase the amount of vitamin D that is permitted in a general sale medicine from 25 micrograms (1,000 IU) to 50 micrograms (2,000 IU). For further information, see the consultation information & questions (PDF document, 467 KB, 7 pages) and the expert opinion report (PDF document, 1.08 MB, 34 pages).
Submissions received
We received 25 submissions. Most respondents self-identified as healthcare professionals, including nurses, general practitioners, nutritionists, naturopaths, and other natural health professionals. Other respondents included researchers, industry representatives, members of the public, and government agencies.
Medsafe would like to thank all those who took the time to respond to the consultation and provided comments.
Outcome
Most respondents agreed with the proposal to increase the amount of vitamin D that is permitted in a general sale medicine from 25 micrograms (1,000 IU) to 50 micrograms (2,000 IU).
Based on the independent expert report, respondent feedback, previous Medicines Classification Committee discussions, and advice from Medsafe, the Minister’s delegate has made the final decision to change the classification of vitamin D as follows:
Prescription; for internal use in medicines containing more than 50 micrograms per recommended daily dose except in parenteral nutrition replacement preparations.
General sale; for external use; for internal use in medicines containing 50 micrograms or less per recommended daily dose; in parenteral nutrition replacement preparations
Implementation date
The classification of vitamin D was implemented via Gazette notice on 19 August 2026.
Enquiries
For any questions about this consultation, please contact committees@health.govt.nz
